摘要
在刚刚落下帷幕的欧洲心脏病学会(ESC)2009年会上,30多项重要临床试验首次披露结果。其中最令人关注的几项临床试验均涉及抗栓治疗,有希望的抗血小板和抗凝新药纷纷登台亮相。
Results of more than 30 clinical trials are released in ESC 2009 that was just concluded. Clinical trial of antithrombotic therapy became the high points, some hopeful new antiplatelet drugs and anticoagulants made their debuts.
出处
《中国处方药》
2009年第10期36-37,共2页
Journal of China Prescription Drug
